Raisa Kurlyandskaya

Affiliations

AstraZeneca Gothenburg, Mölndal, Sweden.

Publications (2)

Sustained 52-week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes.

Diabetes, obesity & metabolism

Avec: Yehuda Handelsman , Chantal Mathieu , Stefano Del Prato , Eva Johnsson , Raisa Kurlyandskaya , Nayyar Iqbal , Ricardo Garcia-Sanchez , Julio Rosenstock

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.

European heart journal

Avec: Hiddo J L Heerspink , C David Sjöström , Niels Jongs , Glenn M Chertow , Mikhail Kosiborod , Fan Fan Hou , John J V McMurray , Peter Rossing , Ricardo Correa-Rotter , Raisa Kurlyandskaya , Bergur V Stefansson , Robert D Toto , Anna Maria Langkilde , David C Wheeler , Auteur inconnu

Réseau de co-auteurs

Yehuda Handelsman 1 collaboration

Chantal Mathieu 1 collaboration

Stefano Del Prato 1 collaboration

Eva Johnsson 1 collaboration

Nayyar Iqbal 1 collaboration

Ricardo Garcia-Sanchez 1 collaboration

Julio Rosenstock 1 collaboration

Hiddo J L Heerspink 1 collaboration

C David Sjöström 1 collaboration

Niels Jongs 1 collaboration

Glenn M Chertow 1 collaboration

Mikhail Kosiborod 1 collaboration

Fan Fan Hou 1 collaboration

John J V McMurray 1 collaboration

Peter Rossing 1 collaboration

Ricardo Correa-Rotter 1 collaboration

Bergur V Stefansson 1 collaboration

Robert D Toto 1 collaboration

Anna Maria Langkilde 1 collaboration

David C Wheeler 1 collaboration

None None 1 collaboration